US Bankruptcy Court gave an order approving the sale of the substantially all the assets related to Biossance brand on December 12, 2023. The debtor has been authorized to sell substantially all Biossance brand?s assets to MenoLabs Brand Assets, the winning bidder at the auction, for a purchase price of $3 million. Under the terms of the asset purchase agreement, the buyer has made an earnest money deposit of $0.03 million upon the execution of the agreement.